Anaplastic Astrocytoma Treatment Market Analysis, Size, Share, Growth, Trends, and Forecast 2021





Anaplastic astrocytoma is a type of malignant brain tumour that is extremely rare. Astrocytomas are tumours that develop from star-shaped astrocytes brain cells. Based on the reproduction rate of the cells and their ability to spread over nearby tissues, the disease has been classified into four groups: Grade I, Grade II, Grade III, and Grade IV. Grade I and Grade II astrocytomas are non-cancerous and are known as low-grade astrocytomas. Grade III and IV astrocytomas, on the other hand, are malignant and are referred to as high-grade astrocytomas. Lower-grade astrocytomas can progress to high-grade astrocytomas over time. Grade III astrocytomas, on the other hand, are also known as anaplastic astrocytomas.

The growing number of drug candidates in the pipeline, which may receive regulatorily approvals during the forecast period are expected to drive the global anaplastic astrocytoma treatment market growth. Currently, the only drug approved by the FDA for Anaplastic Astrocytoma is temozolomide (Temodar). Temodar is an alkylating agent that has been approved for both newly diagnosed patients and refractory anaplastic astrocytoma patients who have seen disease progression despite taking nitrosourea and procarbazine-containing drugs.

Currently, there are three main treatment options for anaplastic astrocytoma: surgery, radiation, and chemotherapy. In the majority of cases, surgery is considered the first line of treatment. Only if the entire tumour cannot be safely excised or removed are patients advised to seek alternative treatment. This treatment pattern, in which drugs are used as a second or third line of treatment, has hampered the sales of pharmaceutical drugs such as Temodar, limiting the growth of the global anaplastic astrocytoma treatment market.





Because of increased awareness about rare diseases such as anaplastic astrocytoma, as well as the presence of leading clinical-stage companies in the region, North America is expected to account for a significant share of the global anaplastic astrocytoma treatment market. The approval of generics for temozolomide will be critical in increasing drug adoption, particularly in emerging economies such as the Asia Pacific and Latin America. The FDA approved American Pharmaceuticals Limited's generic version of Temodar in 2016. The introduction of generic drugs is expected to help the anaplastic astrocytoma treatment market growth.

Taxonomy of the Global Anaplastic Astrocytoma Treatment Market-

By Product Type-

Kinase Inhibitors

Alkylating Agents

Others

By Geography-

Africa

Middle East

Europe

Asia Pacific

North America

Latin America

By Distribution Channel

 

Comments

Post a Comment

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Image
  By 2027, the global market for Quats (Quaternary Ammonium Compounds) is expected to reach USD 1.63 billion. The market is being driven by the rise in the occurrence of hospital-acquired infections (HAIs) and the implementation of stringent regulations and favorable government initiatives on disinfection and sterilization. Developing economies are expected to give significant opportunities for growth. Fabric softeners, disinfectants, surfactants, antistatic agents, and wood preservation are just a few of the uses for quaternary ammonium compounds. The product's numerous applications are projected to raise demand shortly. Quaternary ammonium compounds are commonly employed as conditioning agents in personal care products, such as skin, textile, and hair softeners. The surfactant industry considers QACs to be the ultimate workhorse. They're on the USEPA's "High Production Volume Chemicals" list. Self-assembly, surface-active properties, detergency, and antibact...
Read more

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Image
  Buthylaldehyde (also known as butanal) is a 4-carbon aldehyde that is used as a building block in organic syntheses to make various products such as n-butanol, 2-ethyl hexanol, 2-ethyl hexanoic acid, trimethylolpropane, and polyvinyl butyral. Pharmaceuticals, agrochemicals, antioxidants, textile auxiliaries, perfumes, flavors, and many forms of additives are all made with it as an intermediate (fillers, wetting agents, defoaming agents, improvers). Alcohols (mono- and multi-hydroxide), acids, amines, and esters are all made from N-butyraldehyde as a raw material. Rubber accelerators, synthetic resins, plasticizers, solvents, and high molecular weight polymers are the biggest uses of butyraldehyde. All of these buthylaldehyde applications are detailed in this study. Butyraldehyde is widely used as a starting material for the downstream organic synthesis of n-butanol, trimethylolpropane, 2-ethyl hexanoic acid, and polyvinyl butyral. Pharmaceutical intermediates, synthetic resins,...
Read more

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area

Image
Glass mat thermoplastic is a thermoplastic that can be easily moulded and is used to make a variety of components, primarily in the automotive industry. Because of the longer residual length of the glass strands, glass mat thermoplastic has better mechanical properties than injection moulded reinforced thermoplastic. It is primarily used as a replacement for steel and aluminium. They are available in panel form as well as 3D structural component form. Furthermore, they are a lightweight material with a low relative density, excellent hardness and rigidity at low temperatures, and are chemical and moisture resistant . These are durable materials with ease of recyclability. Furthermore, the demand for the glass mat thermoplastic material from the automobile and aeration industries leads to market growth. When compared to other end-use industries, the automotive application segment is expected to remain the largest. Furthermore, a surge in government initiatives for increased fuel eco...
Read more